Tessera
Folgen

Matthew Davids, MD, MMSc

@drmdavids.bsky.social

Hematologist/oncologist, translational CLL investigator, director of lymphoma clinical research @dana-farber, faculty @harvard med. posts are my own & not medical advice

2 Posts84 Follower68 Folgt
Matthew Davids, MD, MMSc@drmdavids.bsky.social · 11mo ago

Excited to be opening this trial soon @danafarber.bsky.social and several other sites around the globe!

VJHemOnc@vjhemonc.bsky.social · 11mo ago

It was great to catch up with @drmdavids.bsky.social of @danafarber.bsky.social at #iwCLL2025!🎥 Hear as Dr Davids introduces the MAVRiC trial, which will investigate a mutation-guided retreatment strategy using the AV regimen in patients with CLL/SLL in the 2L setting: 👉 buff.ly/aouDK9h #CLLsm